PARLONGO, ROSA MARIA TERESA
 Distribuzione geografica
Continente #
AS - Asia 681
NA - Nord America 358
EU - Europa 237
SA - Sud America 144
AF - Africa 13
OC - Oceania 3
Totale 1.436
Nazione #
SG - Singapore 335
US - Stati Uniti d'America 335
CN - Cina 126
BR - Brasile 117
IT - Italia 94
VN - Vietnam 82
HK - Hong Kong 70
FR - Francia 54
NL - Olanda 17
DE - Germania 13
GB - Regno Unito 13
KR - Corea 12
BD - Bangladesh 11
IN - India 11
AR - Argentina 10
CA - Canada 10
UA - Ucraina 9
JP - Giappone 7
IQ - Iraq 6
MX - Messico 6
FI - Finlandia 5
IE - Irlanda 5
PL - Polonia 5
SE - Svezia 5
AT - Austria 4
EC - Ecuador 4
ID - Indonesia 4
SA - Arabia Saudita 4
UY - Uruguay 4
AU - Australia 3
CO - Colombia 3
ES - Italia 3
GR - Grecia 3
VE - Venezuela 3
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
MY - Malesia 2
PK - Pakistan 2
PY - Paraguay 2
RU - Federazione Russa 2
TN - Tunisia 2
TR - Turchia 2
TT - Trinidad e Tobago 2
ZA - Sudafrica 2
AL - Albania 1
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
DZ - Algeria 1
HU - Ungheria 1
JO - Giordania 1
MA - Marocco 1
MR - Mauritania 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
RW - Ruanda 1
SO - Somalia 1
TG - Togo 1
UZ - Uzbekistan 1
Totale 1.436
Città #
Singapore 198
Santa Clara 103
Hong Kong 70
Lauterbourg 41
San Jose 39
Beijing 38
Ashburn 36
Los Angeles 32
Ho Chi Minh City 24
Hanoi 20
Hefei 13
Seoul 11
Dallas 10
São Paulo 9
New York 8
Amsterdam 7
Dublin 5
Düsseldorf 5
Frankfurt am Main 5
Milan 5
Stockholm 5
Warsaw 5
Bari 4
Haiphong 4
Helsinki 4
Manchester 4
Paternò 4
Thái Bình 4
Tokyo 4
Toronto 4
Da Nang 3
Guarulhos 3
Ha Long 3
Houston 3
Riyadh 3
Sorocaba 3
Aci Catena 2
Athens 2
Belo Horizonte 2
Brooklyn 2
Buenos Aires 2
Campo Grande 2
Can Tho 2
Catalão 2
Catania 2
Curitiba 2
Denver 2
Florianópolis 2
Guayaquil 2
Johannesburg 2
Kingston 2
London 2
Lviv 2
Maringá 2
Marseille 2
Montevideo 2
Mosul 2
Mumbai 2
Mérida 2
Nairobi 2
New Delhi 2
Newark 2
Odesa 2
Orem 2
Osasco 2
Paris 2
Portsmouth 2
Quito 2
Quận Một 2
Ribeirão Preto 2
Rome 2
Salvador 2
San Giovanni la Punta 2
Somma Vesuviana 2
Sydney 2
Trecastagni 2
Vienna 2
Vitória de Santo Antão 2
Vĩnh Yên 2
Aguachica 1
Amman 1
Ananindeua 1
Aracaju 1
Armação dos Búzios 1
Arroyo de La Ventana 1
Assaré 1
Asunción 1
Atlanta 1
Augusta 1
Bacabal 1
Baghdad 1
Bandung 1
Bareilly 1
Barquisimeto 1
Barretos 1
Barueri 1
Basra 1
Baton Rouge 1
Baturité 1
Bauru 1
Totale 846
Nome #
Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy 117
8-hydroxy-2′-deoxyguanosine, a biomarker of oxidative DNA injury, in diabetic kidney disease 94
Neuropeptide y gene polymorphisms and chronic kidney disease progression 72
Role of kidney function on Nrf2 mRNA levels in type 2 diabetes 70
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study 66
The sirtuinl gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study 54
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study 52
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 51
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD 50
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study 47
A POLYMORPHISM IN THE SIRT-1 GENE ASSOCIATES WITH CONCENTRIC REMODELLING OF THE LEFT VENTRICLE AND PREDICTS THE LONGITUDINAL EVOLUTION OF THIS ALTERATION BOTH IN STAGE G1-5 CKD PATIENTS AND IN DIALYSIS PATIENTS 45
Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end stage renal disease. 41
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure 41
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 40
eNOS and Caveolin-1 Gene Polymorphisms Interaction and Intima Media Thickness: A Proof of Concept Study in ESRD Patients. 37
I polimorfismi del gene ENPP1 si associano ad ipertrofia ventricolare sinistra ed alla funzione sistolica nei pazienti in dialisi. 36
Il polimorfismo T585C del gene del recettore Y2 del Neuropeptide Y (NPY2R) interagisce con i livelli plasmatici di NPY nel predire l'ipertrofia ventricolare sinistra (IVS) nei pazienti in dialisi. 32
ENPP1 Gene Polymorphisms are associated with left ventricular (LV) mass and systolic function in end stage renal disease (ESRD) patients. 31
The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity 30
Endothelial nitric oxide sinthase (eNOS) polymorphism interacts with asimmetric dimethyl arginine (ADMA) in determining all cause and cardiovascular mortality in patients with ESRD. 28
Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling. 28
Il sistema metabolico che regola l'ADMA è presente negli adipociti umani ed è iperespresso nell'insufficienza renale. 27
Infiammazione sistemica ed espressione genica nel tessuto adiposo sottocutaneo delle citochine infiammatorie nei pazienti con insufficienza renale cronica. 27
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure. 26
Valore prognostico della variante Glu298Asp dell'ossido nitrico sintetasi (eNOS) e dell'interazione eNOS-Arginina Asimmetrica (ADMA) nei pazienti in dialisi. 24
Le componenti funzionali che controllano la sintesi e la degradazione della dimetil-arginina asimmetrica (ADMA) sono espresse nel tessuto adiposo. 24
Asymmetric Dimethylarginine (ADMA) Enzymatic Machinery and Adipokines Gene Expression in the Adipose Tissue in Stage 3-5 CKD patients. 24
The full ADMA machinery is expressed in human adipocytes: differential regulation in healthy and uremic man. 24
ADMA machinery is expressed in adipocytes in humans and it is differentially regulated in CKD and ESRD patients 24
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 23
The full ADMA machinery is expressed in human adipocytes: differential regulation in healthy and uremic man. 23
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 22
Il polimorfismo T585C del gene del ricettore Y2 del neuropeptide Y (NPY2R) interagisce con i livelli plasmatici di NPY nel determinismo dell'ipertrofia ventricolare sinistra (IVS) nei pazienti in dialisi. 22
I polimorfismi del gene che regola la sintetasi dell'ossido nitrico contribuiscono all'aterosclerosi nei pazienti in dialisi. 22
L'allele T della variante GLU298ASP dell'ossido nitrico sintetasi (eNOS) è un fattore predittivo indipendente di aterosclerosi carotidea nei pazienti in dialisi. 21
Systemic and adipose tissue inflammation in chronic kidney disease (CKD) patients. 20
Methylarginine enzymatic machinery and Leptin in adipose tissue in CKD patients. 20
The interaction of a common variant of the eNOS gene with asymmetric dimethylarginine (ADMA) in carotid atherosclerosis in end stage renal disease (ESRD). 20
Methylarginine enzymatic machinery and Leptin in adipose tissue in CKD patients. 18
eNOS gene polymorphisms contribute to the severity of carotid atherosclerosis in dialysis patients. 18
Systemic and adipose tissue inflammation in chronic kidney disease patients. 17
The severity of carotid atherosclerosis is strongly associated with a polymorphism in the E-selectin gene in patients with end stage renal disease (ESRD). 14
Totale 1.522
Categoria #
all - tutte 5.234
article - articoli 3.006
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.240


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202437 0 0 0 0 0 0 0 0 30 0 7 0
2024/2025626 8 1 51 57 123 10 18 47 48 29 138 96
2025/2026859 28 85 71 112 174 55 139 62 36 62 35 0
Totale 1.522